Cas No.: 199807-33-5
PRODUCT INFORMATION
Description
Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA, also known as Cyclo(RGDfV), is a potent and selective inhibitor of integrin αvβ3. It has demonstrated cytotoxic properties in certain in vitro systems and is often used as a standard research tool in the study of integrin-mediated processes, particularly in acute myeloid leukemia (AML) cell models where this integrin is overexpressed.
Molecular Weight
688.65
Purity
> 95%
Formula
C₂₈H₃₉F₃N₈O₉
Product Type
Targeting Peptide
Sequence
Cyclo[Arg-Gly-Asp-D-Phe-Val]
Form (20 deg.C)
Solid
Storage Condition
Store sealed at -20°C, away from moisture.
For Research Use Only | Not For Clinical Use
Related products
- Somatostatin-28 (1-14) Targeting Peptide (CAT#: OLY-1025-YS-60)
- Cyclo(RGDyK) Targeting Peptide (CAT#: OLY-1025-YS-52)
- Cyclo(Arg-Gly-Asp-D-Phe-Glu) Targeting Peptide (CAT#: OLY-1025-YS-64)
- IETP2 Targeting Peptide (CAT#: OLY-1025-YS-30)
- NGR Peptide TFA (CAT#: OLY-1025-YS-59)
- mUNO Targeting Peptide (CAT#: OLY-1025-YS-29)
- Thrombospondin-1 (1016-1021) (human, Bovine, Mouse) Targeting Peptide (CAT#: OLY-1025-YS-45)
- LyP-2 Targeting Peptide (CAT#: OLY-1025-YS-65)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.